TIGIT表达及其对非小细胞肺癌进展和治疗的影响:系统性审查
Julia Piekarz1, Natalia Picheta1, Katarzyna Szklener2
1Student Academic Group, Department of Clinical Oncology and Chemotherapy, Medical University, 20-090 Lublin, Poland.
International journal of molecular sciences
|October 16, 2025
概括
准TIGIT为非小细胞肺癌 (NSCLC) 提供了一个有前途的新免疫疗法. 将TIGIT阻塞与现有治疗相结合,可以增强抗瘤免疫力,从而有可能改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 现有的免疫疗法,如PD-1/PD-L1抑制剂,面临着原发性和获得性耐药性的挑战.
- 新型免疫治疗策略对于克服NSCLC的耐药性至关重要.
研究的目的:
- 系统地审查新兴的针对NSCLC的TIGIT向疗法.
- 评估TIGIT阻塞在NSCLC治疗中的有效性和安全性.
- 探索涉及TIGIT在NSCLC免疫治疗中的新策略.
主要方法:
- 从2020-2025年使用PICO模型进行系统的文献综述.
- 包括六项研究,包括I-III期临床试验.
- 分析的重点是有效性,安全性和新兴的TIGIT向策略.
主要成果:
- TIGIT阻塞增强了细胞毒性T淋巴细胞和NK细胞活性,增强了抗瘤免疫力.
- 结合提拉古卢马布和PD-1/PD-L1抑制剂的临床试验显示出有前途的协同效应.
- 新兴的策略,如双特异性抗体和细胞疗法正在调查中.
结论:
- 抗TIGIT疗法是NSCLC治疗的一个非常有前途的方法.
- 进一步的生物标志物驱动,精心设计的试验对于验证TIGIT封锁至关重要.
- TIGIT阻塞可能成为NSCLC免疫瘤学策略的关键补充.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


